News & Updates

For chronic heart failure patients requiring cardiac resynchronization therapy (CRT), the use of left bundle branch (LBB) pacing yields superior clinical outcomes compared with the traditional biventricular (BiV) pacing, as shown in the results of the HeartSync-LBBP trial.

At the second interim analysis of part 1 of the phase III RUBY study, updated duration of response (DoR) findings suggest that women with primary advanced or recurrent endometrial cancer who have achieved a response with the combination regimen comprising dostarlimab and carboplatin-paclitaxel (CP) have substantially improved DoR.

Testosterone recovery to a normal level appears predictive of improved overall survival (OS) among men with intermediate-risk prostate cancer who underwent androgen-deprivation therapy (ADT) and radiation therapy (RT), suggests a study.